Informations générales (source: ClinicalTrials.gov)
Optimization of Drug Prescriptions in the Care Pathway for the Elderly, With the Final Objective of Reducing the Iatrogenic Risk. (IATROPREV)
Observational
Centre Hospitalier Universitaire, Amiens (Voir sur ClinicalTrials)
septembre 2021
septembre 2025
29 juin 2024
The IATROPREV project is an organizational innovation experimentation project, carried
out in Hauts-de-France by the University hospitals of Amiens and Lille, the ARS and the
URPS Doctors and Pharmacists of Hauts-de-France and following to the social security
financing law of 2018, allowing experimentation with new organizations in the health
sector, according to article 51. The objectives of this course are to improve the
relevance of prescription in elderly people with multiple drugs as well as, the
coordination of care between the city and the hospital through the sharing of information
and the establishment of multi-professional consultations between the various care
actors.
Etablissements
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Amiens University Hospital - 80054 - Amiens - France | Frédéric BLOCH, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- patient hospitalized in the geriatric medicine department
- Potential involvement of a drug in hospitalization or potential or proven iatrogenic
event during hospitalization;
- Numerous therapeutic modifications (3 or more);
- Drug interaction or introction of a new drug with one or more drug interactions;
- Medicinal product with a narrow therapeutic marge drug requiring close monitoring.
- patient hospitalized in the geriatric medicine department
- Potential involvement of a drug in hospitalization or potential or proven iatrogenic
event during hospitalization;
- Numerous therapeutic modifications (3 or more);
- Drug interaction or introction of a new drug with one or more drug interactions;
- Medicinal product with a narrow therapeutic marge drug requiring close monitoring.
- patient non hospitalized in the geriatric medicine department